Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

M Guberina, K Herrmann, C Pöttgen, N Guberina… - Scientific Reports, 2022 - nature.com
Accurate determination of lymph-node (LN) metastases is a prerequisite for high precision
radiotherapy. The primary aim is to characterise the performance of PET/CT-based machine …

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors

M Guberina, N Guberina, C Pöttgen, T Gauler… - …, 2022 - Taylor & Francis
The pivotal PACIFIC trial defined durvalumab consolidation as the new standard of care in
patients with stage III non-small-cell lung cancer treated with definitive radiochemotherapy …

Long-term survival in patients with oligometastatic non-small cell lung cancer by a multimodality treatment—comparison with stage III disease

M Guberina, C Pöttgen, N Guberina, C Hoffmann… - Cancers, 2024 - mdpi.com
Simple Summary In the present work, we analyzed long-term outcomes of patients with
synchronous oligometastatic (OMD) non-small cell lung cancer (NSCLC) with locally …

Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an …

DP Steinfort, G Kothari, N Wallace… - The Lancet …, 2024 - thelancet.com
Background Systematic mediastinal lymph node staging by endobronchial ultrasound-
guided transbronchial needle aspiration (EBUS-TBNA) improves accuracy of staging in …

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive …

C Richlitzki, M Wiesweg, M Metzenmacher… - Scientific reports, 2024 - nature.com
To evaluate the prognostic value of biomarkers from peripheral blood obtained as routine
laboratory assessment for overall survival in a cohort of stage III non-small cell lung cancer …

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

M Guberina, K Darwiche, H Hautzel, C Pöttgen… - Radiation …, 2021 - Springer
Purpose The aim of this study was to compare the pattern of intra-patient spread of lymph-
node (LN)-metastases within the mediastinum as assessed by 18 F-FDG PET/CT and …

Systematic endoscopic staging of mediastinum to determine impact on radiotherapy for locally advanced lung cancer (SEISMIC): protocol for a prospective single arm …

DP Steinfort, S Siva, K Rangamuwa, P Lee… - BMC pulmonary …, 2022 - Springer
Background Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-
TBNA) is established as the preferred method of mediastinal lymph node (LN) staging in non …

Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms

W Schütte, S Gütz, W Nehls, TG Blum, W Brückl… - …, 2023 - thieme-connect.com
Die aktuelle Fassung der Leitlinie Lungenkarzinom trägt der Dynamik der Informationen in
diesem Fachbereich Rechnung. Insbesondere gelten folgenden Empfehlungen: Die …

[PDF][PDF] 18F-FDGPET/CT 在非小细胞肺癌预后评估中的研究进展

黄丹琪, 刘珈, 李国栋, 刘彩云, 王博平, 马苗苗… - 滨州医学院 … - manu58.magtech.com.cn
肺癌是一种进展迅速的疾病, 预后不良. 准确的治疗前分期和预后评估可改善非小细胞肺癌(
NSCLC) 的诊疗管理. 18F FDGPET/CT 可从分子水平准确地反映肿瘤的生物学特性 …

Place de l'endoscopie dans l'exploration du médiastin, indications et résultats

F Wallyn, C Fournier, V Jounieaux, D Basille - Revue des Maladies …, 2023 - Elsevier
Résumé Depuis les premières publications en 2005 concernant la réalisation de ponctions
transbronchiques médiastinales à l'aiguille échoguidées par échoendoscope linéaire …